Economic Evaluation of Smoking-Cessation Therapies: A Critical and Systematic Review of Simulation Models.
(2012) In PharmacoEconomics 30(7). p.551-564- Abstract
- Background: Smoking is probably the most important among preventable health risks. Health economic evaluation of smoking-cessation interventions, applying a lifetime perspective, is made possible by available epidemiological knowledge. The well established method of performing cost-effectiveness analyses of smoking-cessation interventions involves mathematical modelling (both deterministic and stochastic) of future events important for cost effectiveness. Objectives: This study surveys cost-effectiveness analyses of smoking cessation, with a particular focus on the mathematical modelling and simulation analyses performed. Data Sources: A systematic literature search was performed using the databases MEDLINE, Econlit and Academic Search... (More)
- Background: Smoking is probably the most important among preventable health risks. Health economic evaluation of smoking-cessation interventions, applying a lifetime perspective, is made possible by available epidemiological knowledge. The well established method of performing cost-effectiveness analyses of smoking-cessation interventions involves mathematical modelling (both deterministic and stochastic) of future events important for cost effectiveness. Objectives: This study surveys cost-effectiveness analyses of smoking cessation, with a particular focus on the mathematical modelling and simulation analyses performed. Data Sources: A systematic literature search was performed using the databases MEDLINE, Econlit and Academic Search Complete. Study Selection: Health economic evaluations, published as full-length journal articles, were searched for. Results: 423 studies were identified and 78 were finally included, of which 30 were assessed as being highly relevant, based on the application of simulation modelling. Conclusions: In general, studies are well performed as regards modelling. Common weaknesses include reporting of modelling details; validation of used simulation models; and the handling of structural uncertainty and different types of heterogeneity. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/2608800
- author
- Bolin, Kristian LU
- organization
- publishing date
- 2012
- type
- Contribution to journal
- publication status
- published
- subject
- in
- PharmacoEconomics
- volume
- 30
- issue
- 7
- pages
- 551 - 564
- publisher
- Adis International
- external identifiers
-
- wos:000305817200002
- scopus:84862219638
- pmid:22591112
- ISSN
- 1179-2027
- DOI
- 10.2165/11590120-000000000-00000
- language
- English
- LU publication?
- yes
- id
- 0b7f07b9-7618-497f-b6aa-e13994be22b1 (old id 2608800)
- date added to LUP
- 2016-04-01 10:57:44
- date last changed
- 2022-03-27 21:10:46
@article{0b7f07b9-7618-497f-b6aa-e13994be22b1,
abstract = {{Background: Smoking is probably the most important among preventable health risks. Health economic evaluation of smoking-cessation interventions, applying a lifetime perspective, is made possible by available epidemiological knowledge. The well established method of performing cost-effectiveness analyses of smoking-cessation interventions involves mathematical modelling (both deterministic and stochastic) of future events important for cost effectiveness. Objectives: This study surveys cost-effectiveness analyses of smoking cessation, with a particular focus on the mathematical modelling and simulation analyses performed. Data Sources: A systematic literature search was performed using the databases MEDLINE, Econlit and Academic Search Complete. Study Selection: Health economic evaluations, published as full-length journal articles, were searched for. Results: 423 studies were identified and 78 were finally included, of which 30 were assessed as being highly relevant, based on the application of simulation modelling. Conclusions: In general, studies are well performed as regards modelling. Common weaknesses include reporting of modelling details; validation of used simulation models; and the handling of structural uncertainty and different types of heterogeneity.}},
author = {{Bolin, Kristian}},
issn = {{1179-2027}},
language = {{eng}},
number = {{7}},
pages = {{551--564}},
publisher = {{Adis International}},
series = {{PharmacoEconomics}},
title = {{Economic Evaluation of Smoking-Cessation Therapies: A Critical and Systematic Review of Simulation Models.}},
url = {{http://dx.doi.org/10.2165/11590120-000000000-00000}},
doi = {{10.2165/11590120-000000000-00000}},
volume = {{30}},
year = {{2012}},
}